Texas A&M Researchers Develop Laser Technique That Directly Measures Quantum Forces Driving Protein Interactions
Key Insights
Researchers at Texas A&M University invented Thermostable Raman Interaction Profiling (TRIP), a laser-based technique that directly measures quantum forces governing protein interactions for the first time.
TRIP detects pi-pi stacking, a subtle molecular interaction critical to protein structure and drug binding, by monitoring vibrational shifts in the amino acid phenylalanine.
When tested on the SARS-CoV-2 (search) main protease (Mpro), TRIP accurately predicted antiviral drug potency, with stronger drugs producing more pronounced vibrational signatures.
Researchers at Texas A&M University have achieved what was previously considered impossible: directly measuring the quantum forces that shape proteins and govern how pharmaceutical drugs interact with them. The breakthrough, published in Science Advances, introduces a laser-based technique called Thermostable Raman Interaction Profiling (TRIP) that offers an unprecedented real-time view of atomic-level molecular interactions.
"For the first time, we can directly measure molecular forces at their most fundamental level," said Dr. Narangerel Altangerel, assistant research scientist in the Department of Electrical and Computer Engineering and lead researcher of the project. "We can directly use these measurements as a predictive tool for drug development, far beyond a single virus or disease."
The Quantum Velcro Hiding in Plain Sight
At the heart of TRIP lies its ability to detect pi-pi stacking, a subtle geometric interaction between ring-shaped molecules that is ubiquitous in biological systems. These interactions hold the three-dimensional structure of DNA and proteins together and play a major role in how medications exert their therapeutic effects.
"Pi-pi interactions are a cornerstone of biology, materials science and drug design," explained Dr. Philip Hemmer, professor of electrical and computer engineering at the Texas A&M University College of Engineering. "Think of them as biology's Velcro. They hold the 3D structuring of molecules like DNA and proteins in living systems and play a major role in how medications work."
For decades, scientists have recognized the importance of these quantum forces but lacked the tools to quantify them directly within complex biological systems. Traditional methods such as X-ray crystallography and mass spectroscopy, while useful, rely on visual intuition and indirect inference rather than direct measurement.
Turning Molecular Vibrations into Readable Signals
TRIP employs a Raman-based approach, firing a laser at a sample and analyzing the unique vibrational signals that return. The team discovered that the "benzene ring breathing" vibration of the amino acid phenylalanine acts as a sensitive reporter of pi-pi stacking. When ring-shaped molecules move closer together and stack, their vibration shifts — and TRIP captures those tiny frequency shifts, translating them into a direct readout of the interaction.
"It's a classical technique used to capture quantum effects," Altangerel said. "We turned molecular vibrations into a readable signal. It's like listening to the music of a molecule and hearing how its internal forces change in real time."
Validating TRIP Against a Familiar Foe
The team selected the SARS-CoV-2 (search) main protease (Mpro) as their testing model due to its biological and clinical relevance. Mpro is particularly suited for studying pi-pi stacking because it only becomes active as a dimer — when two copies bind together, pi-pi stacking initiates the process.
As Mpro shifted between active and inactive states, the researchers observed corresponding changes to its vibrational signature in real time. "I felt disbelief," Altangerel recalled. "These changes weren't random, they were systematic and they were direct indicators of vibrational shifts."
The team confirmed their findings using density functional theory (DFT), a quantum mechanical method that relies on supercomputers to model phenomena like pi-pi stacking. "The calculations matched the direct measurements almost perfectly," Altangerel said.
Predicting Drug Potency at the Quantum Scale
The true power of TRIP emerged when the researchers exposed the viral protein to various antiviral medications. A clear correlation materialized: the stronger the drug's antiviral potency, the more pronounced the vibrational signature detected by TRIP — a relationship that held up across multiple measurements.
"It was an exciting result," Altangerel noted. "A quantum-scale interaction predicted real-world biological performance."
This predictive capability represents a significant advancement for pharmaceutical development. "Our technique is non-invasive and can expedite the testing and prescreening of pharmaceutical drugs, with the aim to improve overall human health," Hemmer said.
Beyond a Single Virus: Broad Applications in Drug Discovery
The implications of TRIP extend far beyond virology. In cancer, the technique could help scientists evaluate drugs capable of disrupting protein networks that drive tumor growth. In Alzheimer's disease, it could assess which compounds stabilize healthy proteins in brain cells or detect the earliest changes associated with neurodegeneration. Across infectious diseases, researchers can now directly observe how different pharmaceutical drugs target and weaken the protein machinery viruses rely on, helping identify the strongest candidates long before they reach clinical trials.
"By understanding these quantum interactions directly, we can start designing medicines with a level of precision that wasn't possible before, applied for a spectrum of diseases," Altangerel concluded.
The project was supported by the Air Force Office of Scientific Research, the National Institutes of Health, Google, and the Army Research Laboratory. Altangerel and her team have filed a U.S. patent for the invention, marking a major milestone in what could become a breakthrough technology for pharmaceutical development and discovery.
"Our work introduces more than just a new technique," Altangerel said. "Our aim is to transition it from technique to protocol, to aid in the acceleration and discovery of next-generation medications."